162 related articles for article (PubMed ID: 16541276)
1. Functional studies of two novel and two rare mutations in the 21-hydroxylase gene.
Barbaro M; Baldazzi L; Balsamo A; Lajic S; Robins T; Barp L; Pirazzoli P; Cacciari E; Cicognani A; Wedell A
J Mol Med (Berl); 2006 Jun; 84(6):521-8. PubMed ID: 16541276
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of two recurrent amino acid substitutions in the CYP21 gene from Italian patients with congenital adrenal hyperplasia.
Barbaro M; Lajic S; Baldazzi L; Balsamo A; Pirazzoli P; Cicognani A; Wedell A; Cacciari E
J Clin Endocrinol Metab; 2004 May; 89(5):2402-7. PubMed ID: 15126570
[TBL] [Abstract][Full Text] [Related]
3. A rare CYP 21 mutation (p.E431K) induced deactivation of CYP 21A2 and resulted in congenital adrenal hyperplasia.
Kawashima Y; Usui T; Fujimoto M; Miyahara N; Nishimura R; Hanaki K; Kanzaki S
Endocr J; 2015; 62(1):101-6. PubMed ID: 25319875
[TBL] [Abstract][Full Text] [Related]
4. Phenotype-genotype correlations of 13 rare CYP21A2 mutations detected in 46 patients affected with 21-hydroxylase deficiency and in one carrier.
Tardy V; Menassa R; Sulmont V; Lienhardt-Roussie A; Lecointre C; Brauner R; David M; Morel Y
J Clin Endocrinol Metab; 2010 Mar; 95(3):1288-300. PubMed ID: 20080860
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of two rare CYP21A2 mutations detected in Italian patients with a mildest form of congenital adrenal hyperplasia.
Concolino P; Vendittelli F; Mello E; Minucci A; Carrozza C; Rossodivita A; Giardina B; Zuppi C; Capoluongo E
Clin Endocrinol (Oxf); 2009 Oct; 71(4):470-6. PubMed ID: 19170707
[TBL] [Abstract][Full Text] [Related]
6. Three novel point mutations of the CYP21 gene detected in classical forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Krone N; Riepe FG; Partsch CJ; Vorhoff W; Brämswig J; Sippell WG
Exp Clin Endocrinol Diabetes; 2006 Mar; 114(3):111-7. PubMed ID: 16636976
[TBL] [Abstract][Full Text] [Related]
7. Functional analysis of four CYP21 mutations from spanish patients with congenital adrenal hyperplasia.
Nunez BS; Lobato MN; White PC; Meseguer A
Biochem Biophys Res Commun; 1999 Sep; 262(3):635-7. PubMed ID: 10471376
[TBL] [Abstract][Full Text] [Related]
8. Functional and structural analysis of four novel mutations of CYP21A2 gene in Italian patients with 21-hydroxylase deficiency.
Massimi A; Malaponti M; Federici L; Vinciguerra D; Manca Bitti ML; Vottero A; Ghizzoni L; Maccarrone M; Cappa M; Bernardini S; Porzio O
Horm Metab Res; 2014 Jun; 46(7):515-20. PubMed ID: 24799024
[TBL] [Abstract][Full Text] [Related]
9. Four novel missense mutations in the CYP21A2 gene detected in Russian patients suffering from the classical form of congenital adrenal hyperplasia: identification, functional characterization, and structural analysis.
Grischuk Y; Rubtsov P; Riepe FG; Grötzinger J; Beljelarskaia S; Prassolov V; Kalintchenko N; Semitcheva T; Peterkova V; Tiulpakov A; Sippell WG; Krone N
J Clin Endocrinol Metab; 2006 Dec; 91(12):4976-80. PubMed ID: 16984992
[TBL] [Abstract][Full Text] [Related]
10. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
[TBL] [Abstract][Full Text] [Related]
11. CYP21 mutations in simple virilizing congenital adrenal hyperplasia.
Lajić S; Robins T; Krone N; Schwarz HP; Wedell A
J Mol Med (Berl); 2001 Oct; 79(10):581-6. PubMed ID: 11692155
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effect of partially inactivating mutations in steroid 21-hydroxylase deficiency.
Nikoshkov A; Lajic S; Holst M; Wedell A; Luthman H
J Clin Endocrinol Metab; 1997 Jan; 82(1):194-9. PubMed ID: 8989258
[TBL] [Abstract][Full Text] [Related]
13. Three novel CYP21A2 mutations and their protein modelling in patients with classical 21-hydroxylase deficiency from northeastern Iran.
Baradaran-Heravi A; Vakili R; Robins T; Carlsson J; Ghaemi N; A'rabi A; Abbaszadegan MR
Clin Endocrinol (Oxf); 2007 Sep; 67(3):335-41. PubMed ID: 17573904
[TBL] [Abstract][Full Text] [Related]
14. Mutational characterization of steroid 21-hydroxylase gene in Portuguese patients with congenital adrenal hyperplasia.
Marques CJ; Pignatelli D; Carvalho B; Barceló J; Almeida AC; Fernandes S; Witchel SF; Sousa M; Oliveira MJ; Freitas P; Fontoura M; Carvalho D; Barros A; Carvalho F
Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):505-12. PubMed ID: 19856253
[TBL] [Abstract][Full Text] [Related]
15. Functional studies of p.R132C, p.R149C, p.M283V, p.E431K, and a novel c.652-2A>G mutations of the CYP21A2 gene.
Taboas M; Gómez Acuña L; Scaia MF; Bruque CD; Buzzalino N; Stivel M; Ceballos NR; Dain L
PLoS One; 2014; 9(3):e92181. PubMed ID: 24667412
[TBL] [Abstract][Full Text] [Related]
16. Novel non-classic CYP21A2 variants, including combined alleles, identified in patients with congenital adrenal hyperplasia.
Karlsson L; de Paula Michelatto D; Lusa ALG; D'Almeida Mgnani Silva C; Östberg LJ; Persson B; Guerra-Júnior G; Valente de Lemos-Marini SH; Baldazzi L; Menabó S; Balsamo A; Greggio NA; Palandi de Mello M; Barbaro M; Lajic S
Clin Biochem; 2019 Nov; 73():50-56. PubMed ID: 31344365
[TBL] [Abstract][Full Text] [Related]
17. p.H282N and p.Y191H: 2 novel CYP21A2 mutations in Italian congenital adrenal hyperplasia patients.
Concolino P; Mello E; Patrosso MC; Penco S; Zuppi C; Capoluongo E
Metabolism; 2012 Apr; 61(4):519-24. PubMed ID: 22014889
[TBL] [Abstract][Full Text] [Related]
18. A new CYP21A2 nonsense mutation causing severe 21-hydroxylase deficiency.
Concolino P; Minucci A; Mello E; Zuppi C; Capoluongo E
Clin Chem Lab Med; 2009; 47(7):824-5. PubMed ID: 19499972
[TBL] [Abstract][Full Text] [Related]
19. Genotype-phenotype analysis in late onset 21-hydroxylase deficiency in comparison to the classical forms.
Rumsby G; Avey CJ; Conway GS; Honour JW
Clin Endocrinol (Oxf); 1998 Jun; 48(6):707-11. PubMed ID: 9713558
[TBL] [Abstract][Full Text] [Related]
20. In vitro functional studies of rare CYP21A2 mutations and establishment of an activity gradient for nonclassic mutations improve phenotype predictions in congenital adrenal hyperplasia.
Barbaro M; Soardi FC; Östberg LJ; Persson B; de Mello MP; Wedell A; Lajic S
Clin Endocrinol (Oxf); 2015 Jan; 82(1):37-44. PubMed ID: 24953648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
